Microneedle-Based Delivery: An Overview of Current Applications and Trends.
Antonio José GuillotAna Sara CordeiroRyan F DonellyMaría Carmen MontesinosTeresa M GarriguesAna MeleroPublished in: Pharmaceutics (2020)
Microneedle arrays (MNA) are considered as one of the most promising resources to achieve systemic effects by transdermal delivery of drugs. They are designed as a minimally invasive, painless system which can bypass the stratum corneum, overcoming the potential drawbacks of subcutaneous injections and other transdermal delivery systems such as chemical enhancers, nano and microparticles, or physical treatments. As a trendy field in pharmaceutical and biomedical research, its applications are constantly evolving, even though they are based on very well-established techniques. The number of molecules administered by MNA are also increasing, with insulin and vaccines administration being the most investigated. Furthermore, MNA are being used to deliver cells and applied in other organs and tissues like the eyes and buccal mucosae. This review intends to offer a general overview of the current state of MNA research, focusing on the strategies, applications, and types of molecules delivered recently by these systems. In addition, some information about the materials and manufacturing processes is presented and safety data is discussed.
Keyphrases
- minimally invasive
- induced apoptosis
- type diabetes
- cell cycle arrest
- mental health
- electronic health record
- optical coherence tomography
- healthcare
- big data
- endoplasmic reticulum stress
- platelet rich plasma
- atomic force microscopy
- oxidative stress
- cell death
- high resolution
- machine learning
- health information
- skeletal muscle
- signaling pathway
- metabolic syndrome
- deep learning
- cell proliferation
- human health
- mass spectrometry
- climate change
- social media
- pi k akt
- high speed
- data analysis